New drug aims to protect hearts during major attacks
NCT ID NCT06465303
Summary
This study is testing if a new drug called RTP-026 can help reduce heart muscle damage in people who have just had a major heart attack (STEMI). About 96 participants will receive either the drug or a placebo through three IV infusions shortly after their standard artery-opening procedure. The main goal is to see if the drug is safe and if it helps lower levels of heart damage markers in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ST ELEVATION MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hjertecenteret, Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact
Conditions
Explore the condition pages connected to this study.